Evogene Market Cap

Evogene has a market cap or net worth of $7.42 million as of April 21, 2025. Its market cap has decreased by -80.08% in one year.

Market Cap

7.42M

Enterprise Value

10.82M

1-Year Change

-80.08%

Ranking

#5148

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $7.42M, a decrease of -73.52%. That is a compound annual growth rate of -7.30%.

Market Cap History

Date	Market Cap	% Change
Apr 21, 2025	7.42M	-42.95%
Dec 31, 2024	13.00M	-69.10%
Dec 31, 2023	42.08M	60.85%
Dec 29, 2022	26.16M	-63.27%
Dec 30, 2021	71.23M	-58.31%
Dec 31, 2020	170.86M	335.98%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	754.27B
UnitedHealth Group	415.38B
Johnson & Johnson	379.48B
AbbVie	306.02B
Novo Nordisk	284.50B
Abbott Laboratories	227.16B
Novartis AG	209.93B
AstraZeneca	208.11B

Market Cap Rankings